Dr. Shijun Zhang Receives Two Year Grant

August 25, 2020

Dr. Shijun Zhang is the recipient of a supplement to his current R01 grant titled 'Development of NLRP3 inflammasome inhibitors towards Alzheimer's disease'. Congratulations Dr. Zhang.